Follow
Aubin Michalon
Aubin Michalon
Neurimmune Holding AG
Verified email at neurimmune.com
Title
Cited by
Cited by
Year
Epigenetic transmission of the impact of early stress across generations
TB Franklin, H Russig, IC Weiss, J Gräff, N Linder, A Michalon, S Vizi, ...
Biological psychiatry 68 (5), 408-415, 2010
13272010
Protein phosphatase 1 is a molecular constraint on learning and memory
D Genoux, U Haditsch, M Knobloch, A Michalon, D Storm, IM Mansuy
Nature 418 (6901), 970-975, 2002
5662002
Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice
A Michalon, M Sidorov, TM Ballard, L Ozmen, W Spooren, JG Wettstein, ...
Neuron 74 (1), 49-56, 2012
5512012
NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory
BJ Saab, J Georgiou, A Nath, FJS Lee, M Wang, A Michalon, F Liu, ...
Neuron 63 (5), 643-656, 2009
2322009
CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor
L Lindemann, G Jaeschke, A Michalon, E Vieira, M Honer, W Spooren, ...
Journal of Pharmacology and Experimental Therapeutics 339 (2), 474-486, 2011
1272011
Drug discovery for autism spectrum disorder: challenges and opportunities
A Ghosh, A Michalon, L Lindemann, P Fontoura, L Santarelli
Nature Reviews Drug Discovery 12 (10), 777-790, 2013
1252013
Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice
A Michalon, A Bruns, C Risterucci, M Honer, TM Ballard, L Ozmen, ...
Biological psychiatry 75 (3), 189-197, 2014
852014
Inducible and neuron‐specific gene expression in the adult mouse brain with the rtTA2S‐M2 system
A Michalon, K Koshibu, K Baumgärtel, DH Spirig, IM Mansuy
Genesis 43 (4), 205-212, 2005
692005
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid
P Garcia-Pavia, F Aus dem Siepen, E Donal, O Lairez, P van der Meer, ...
New England Journal of Medicine, 2023
432023
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
A Michalon, A Hagenbuch, C Huy, E Varela, B Combaluzier, T Damy, ...
Nature communications 12 (1), 3142, 2021
432021
Molecular pathophysiology of fragile X-associated tremor/ataxia syndrome and perspectives for drug development
T Botta-Orfila, GG Tartaglia, A Michalon
The Cerebellum 15, 599-610, 2016
232016
Characterization of conformation-specific, human-derived monoclonal antibodies against TTR aggregates with potential for diagnostic and therapeutic use
A Michalon, B Combaluzier, E Varela, A Hagenbuch, O Suhr, M Saraiva, ...
Orphanet Journal of Rare Diseases 10 (1), 1-1, 2015
32015
Combination therapy for ttr amyloidosis
A Michalon, J Grimm
US Patent App. 17/924,496, 2023
2023
Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor
J Grimm, A Michalon
US Patent App. 17/532,292, 2022
2022
Patient-derived amyloid xenograft non-human animal model
A Michalon, J Grimm
US Patent App. 17/292,107, 2021
2021
Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor
J Grimm, A Michalon
US Patent 11,180,545, 2021
2021
Antibody-based therapy of transthyretin (TTR) amyloidosis and human-derived antibodies therefor
J Grimm, A Michalon
US Patent 10,344,080, 2019
2019
Investigating Therapeutic Strategies for Fragile X Syndrome in Mice
A Michalon, L Lindemann
Genetically Modified Organisms and Genetic Engineering in Research and …, 2012
2012
Dual approach to study the impact of glycine-mediated modulation of glutamatergic transmission on behaviour
A Michalon
ETH Zurich, 2005
2005
Genetic systems for inducible and reversible gene recombination and expression in the mouse brain
K Baumgärtel, A Michalon, K Koshibu, D Spirig, IM Mansuy
NCCR Neural Plasticity and Repair Symposium 2005, 2005
2005
The system can't perform the operation now. Try again later.
Articles 1–20